Cytochrome-c Oxidase Deficiency
|
0.940 |
GeneticVariation
|
disease |
BEFREE |
Overexpression of known pathogenic variants in SCO1 fibroblasts showed that p.G132S exacerbated the COX deficiency, whereas COX activity was partially or fully restored by p.P174L and p.M294V, respectively.
|
23878101 |
2013 |
Cytochrome-c Oxidase Deficiency
|
0.940 |
GeneticVariation
|
disease |
BEFREE |
Mutations in both SCO1 and SCO2 are associated with distinct clinical phenotypes as well as tissue-specific COX deficiency, but the reason for such tissue specificity is unknown.
|
20864674 |
2010 |
Cytochrome-c Oxidase Deficiency
|
0.940 |
GeneticVariation
|
disease |
UNIPROT |
Human SCO2 is required for the synthesis of CO II and as a thiol-disulphide oxidoreductase for SCO1.
|
19336478 |
2009 |
Cytochrome-c Oxidase Deficiency
|
0.940 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
A novel homozygous SCO2 mutation, p.G193S, causing fatal infantile cardioencephalomyopathy.
|
19353847 |
2009 |
Cytochrome-c Oxidase Deficiency
|
0.940 |
GeneticVariation
|
disease |
UNIPROT |
Human Sco1 functional studies and pathological implications of the P174L mutant.
|
17182746 |
2007 |
Cytochrome-c Oxidase Deficiency
|
0.940 |
GeneticVariation
|
disease |
UNIPROT |
The human cytochrome c oxidase assembly factors SCO1 and SCO2 have regulatory roles in the maintenance of cellular copper homeostasis.
|
17189203 |
2007 |
Cytochrome-c Oxidase Deficiency
|
0.940 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Neonatal seizures and limb malformations associated with liver-specific complex IV respiratory chain deficiency.
|
15023375 |
2004 |
Cytochrome-c Oxidase Deficiency
|
0.940 |
GeneticVariation
|
disease |
BEFREE |
Mutations of the SCO1 gene in mitochondrial cytochrome c oxidase deficiency with neonatal-onset hepatic failure and encephalopathy.
|
11013136 |
2000 |
Cytochrome-c Oxidase Deficiency
|
0.940 |
Biomarker
|
disease |
BEFREE |
We conclude that neither SCO1 nor COX17 are common causes of COX deficiency disorders.
|
11027508 |
2000 |
Cytochrome-c Oxidase Deficiency
|
0.940 |
GeneticVariation
|
disease |
UNIPROT |
Studying a large family with multiple cases of neonatal ketoacidotic comas and isolated COX deficiency, we have mapped the disease locus to chromosome 17p13.1, in a region encompassing two candidate genes involved in COX assembly-namely, SCO1 and COX10.
|
11013136 |
2000 |
Cytochrome-c Oxidase Deficiency
|
0.940 |
Biomarker
|
disease |
MGD |
|
|
|
Cytochrome-c Oxidase Deficiency
|
0.940 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Cytochrome-c Oxidase Deficiency
|
0.940 |
Biomarker
|
disease |
CTD_human |
|
|
|
Cytochrome-c Oxidase Deficiency
|
0.940 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Mitochondrial Diseases
|
0.520 |
GeneticVariation
|
group |
BEFREE |
Mitochondrial Disease Caused by a Novel Homozygous Mutation (Gly106del) in the SCO1 Gene.
|
31352446 |
2019 |
Mitochondrial Diseases
|
0.520 |
Biomarker
|
group |
GENOMICS_ENGLAND |
Advantages and pitfalls of an extended gene panel for investigating complex neurometabolic phenotypes.
|
27604308 |
2016 |
Mitochondrial Diseases
|
0.520 |
Biomarker
|
group |
BEFREE |
Unexpected vascular enrichment of SCO1 over SCO2 in mammalian tissues: implications for human mitochondrial disease.
|
20864674 |
2010 |
Mitochondrial Diseases
|
0.520 |
Biomarker
|
group |
CTD_human |
Human Sco1 functional studies and pathological implications of the P174L mutant.
|
17182746 |
2007 |
Mitochondrial Diseases
|
0.520 |
Biomarker
|
group |
GENOMICS_ENGLAND |
|
|
|
Encephalopathies
|
0.330 |
GeneticVariation
|
group |
BEFREE |
Here, we present a novel mutation in the SCO1 gene: in-frame deletion (Gly106del)with a different phenotype without encephalopathy, hepatopathy, hypotonia, or cardiac involvement.
|
31352446 |
2019 |
Encephalopathies
|
0.330 |
GeneticVariation
|
group |
BEFREE |
Here, we identified novel compound heterozygous mutations in SCO1 (p.M294V, p.Val93*) in one such patient with fatal encephalopathy.
|
23878101 |
2013 |
Encephalopathies
|
0.330 |
Biomarker
|
group |
CTD_human |
COX19 mediates the transduction of a mitochondrial redox signal from SCO1 that regulates ATP7A-mediated cellular copper efflux.
|
23345593 |
2013 |
Encephalopathies
|
0.330 |
GeneticVariation
|
group |
BEFREE |
Mutations of the SCO1 gene in mitochondrial cytochrome c oxidase deficiency with neonatal-onset hepatic failure and encephalopathy.
|
11013136 |
2000 |
Liver diseases
|
0.320 |
GeneticVariation
|
group |
BEFREE |
The patient lacked the severe hepatopathy (p.P174L) or hypertrophic cardiomyopathy (p.G132S) observed in previously reported SCO1 cases, so we investigated whether allele-specific defects in SCO1 function might underlie the genotype-phenotype relationships.
|
23878101 |
2013 |
Liver diseases
|
0.320 |
Biomarker
|
group |
CTD_human |
COX19 mediates the transduction of a mitochondrial redox signal from SCO1 that regulates ATP7A-mediated cellular copper efflux.
|
23345593 |
2013 |